Nakahara Memorial Lecture. Pathways of carcinogenesis--genetic and epigenetic. 1991

H C Pitot, and Y Dragan, and Y H Xu, and J Peterson, and J Hully, and H Campbell
McArdle Laboratory for Cancer Research, Department of Oncology, Medical School, University of Wisconsin, Madison 53706.

Considerable experimental evidence has developed to argue that carcinogenesis occurs in a series of stages whose characteristics allow division into the distinct stages of initiation, promotion, and progression. The stage of initiation results from subtle genetic alterations in individual target cells caused both by experimental perturbations as well as by ambient environmental factors. Initiation of a cell may result from the mutation of one or a few key genes whose expression is modified by many other genes. Promoting agents induce the clonal development of initiated cells susceptible to the proliferative effects of the specific promoting agent. The stage of progression is characterized by evolving karyotypic instability and may be induced by specific clastogenic effects and/or agents, the latter termed progressor agents. Carcinogens may induce cancer by an action at all three stages or selectively by an action at any one or two of the individual stages of carcinogenesis. Cancer then develops as a result of fortuitous, endogenous, or ambient environmental factors, thus accounting for the action of both genotoxic and nongenotoxic agents as carcinogens.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D003043 Cocarcinogenesis The combination of two or more different factors in the production of cancer. Cocarcinogeneses
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

H C Pitot, and Y Dragan, and Y H Xu, and J Peterson, and J Hully, and H Campbell
January 1990, Princess Takamatsu symposia,
H C Pitot, and Y Dragan, and Y H Xu, and J Peterson, and J Hully, and H Campbell
January 1987, Princess Takamatsu symposia,
H C Pitot, and Y Dragan, and Y H Xu, and J Peterson, and J Hully, and H Campbell
January 1985, Princess Takamatsu symposia,
H C Pitot, and Y Dragan, and Y H Xu, and J Peterson, and J Hully, and H Campbell
January 1989, Princess Takamatsu symposia,
H C Pitot, and Y Dragan, and Y H Xu, and J Peterson, and J Hully, and H Campbell
January 1988, Princess Takamatsu symposia,
H C Pitot, and Y Dragan, and Y H Xu, and J Peterson, and J Hully, and H Campbell
January 1983, Princess Takamatsu symposia,
H C Pitot, and Y Dragan, and Y H Xu, and J Peterson, and J Hully, and H Campbell
January 1968, The New Zealand medical journal,
H C Pitot, and Y Dragan, and Y H Xu, and J Peterson, and J Hully, and H Campbell
October 2003, Biochemical Society transactions,
H C Pitot, and Y Dragan, and Y H Xu, and J Peterson, and J Hully, and H Campbell
July 2022, Faraday discussions,
H C Pitot, and Y Dragan, and Y H Xu, and J Peterson, and J Hully, and H Campbell
January 1986, Princess Takamatsu symposia,
Copied contents to your clipboard!